Takeda Pharmaceutical (TAK) Raw Materials (2019)
Takeda Pharmaceutical (TAK) posted quarterly Raw Materials of $182.2 million for Q1 2019.
Takeda Pharmaceutical (TAK) Raw Materials (2019) Analysis & Trends
Takeda Pharmaceutical's Raw Materials history runs 1 years deep, the most recent figure standing at $182.2 million for Q1 2019.
- In Q1 2019, Raw Materials changed N/A year-over-year to $182.2 million; the TTM figure through Mar 2019 stood at $182.2 million (changed N/A YoY), while the FY2019 annual figure was $182.2 million, changed N/A from the prior year.
- Raw Materials for Q1 2019 stood at $182.2 million.
- The five-year high for Raw Materials was $182.2 million in Q1 2019, with the low at $182.2 million in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - |
| 10 | Alkermes | 8.20 Bn | 7.54 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 182.17 Mn |